IMO, it more and more likely that the deal will be made with big pharma. They have more than 1 billion to invest, they need to find new patented drugs and they have the skills to get PBT2 to the market. So the fund will be left with their 1 billion to support those developments left outside what PBT2 will be able to kill if there are any bacteria left. Nobody knows what are these leftovers so it may take a while before they can support any efforts. Perhaps the fund will give a few hundred million to ATH to be part of the PBT2 success.
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $67 | 13.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 40123044 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 17787904 | 20 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.6¢ | 0.5¢ | 4997767 | ||
| Last updated 15.10pm 24/05/2024 ? | |||||
| ATH (ASX) Chart |